2548 related articles for article (PubMed ID: 12828109)
41. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
[TBL] [Abstract][Full Text] [Related]
42. Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer.
Chipponi J; Huguier M; Pezet D; Basso N; Hay JM; Quandalle P; Jaeck D; Fagniez PL; Gainant A
Am J Surg; 2004 Mar; 187(3):440-5. PubMed ID: 15006580
[TBL] [Abstract][Full Text] [Related]
43. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
44. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
[TBL] [Abstract][Full Text] [Related]
45. Current status and future perspectives in gastric cancer management.
Roukos DH
Cancer Treat Rev; 2000 Aug; 26(4):243-55. PubMed ID: 10913380
[TBL] [Abstract][Full Text] [Related]
46. Long-term treatment of localized gastric marginal zone B-cell mucosa associated lymphoid tissue lymphoma including incidence of metachronous gastric cancer.
Ono S; Kato M; Takagi K; Kodaira J; Kubota K; Matsuno Y; Komatsu Y; Asaka M
J Gastroenterol Hepatol; 2010 Apr; 25(4):804-9. PubMed ID: 20492338
[TBL] [Abstract][Full Text] [Related]
47. Role of lymph node dissection and splenectomy in node-positive gastric carcinoma.
Adachi Y; Kamakura T; Mori M; Maehara Y; Sugimachi K
Surgery; 1994 Nov; 116(5):837-41. PubMed ID: 7940186
[TBL] [Abstract][Full Text] [Related]
48. General and specific prognostic factors of early gastric carcinoma treated with curative surgery.
Isozaki H; Tanaka N; Okajima K
Hepatogastroenterology; 1999; 46(27):1800-8. PubMed ID: 10430349
[TBL] [Abstract][Full Text] [Related]
49. Prognostic factors in patients with advanced gastric cancer treated by noncurative resection: a multivariate analysis.
Tsujitani S; Oka S; Suzuki K; Saito H; Kondo A; Ikeguchi M; Maeta M; Kaibara N
Hepatogastroenterology; 2001; 48(41):1504-8. PubMed ID: 11677996
[TBL] [Abstract][Full Text] [Related]
50. [A clinicopathological analysis of gastric lymphoma].
Xue LY; Lü N; Li AD; Zou SM; Lin DM; He ZG; Xie YQ; Liu XY
Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):332-6. PubMed ID: 16185499
[TBL] [Abstract][Full Text] [Related]
51. Reassessment of gastric lymphoma in light of the concept of mucosa-associated lymphoid tissue lymphoma: analysis of 53 patients.
Hoshida Y; Kusakabe H; Furukawa H; Kasugai T; Miwa H; Ishiguro S; Aozasa K
Cancer; 1997 Sep; 80(6):1151-9. PubMed ID: 9305717
[TBL] [Abstract][Full Text] [Related]
52. Indications for paraaortic lymph node dissection in gastric cancer patients with paraaortic lymph node involvement.
Kunisaki C; Shimada H; Yamaoka H; Takahashi M; Ookubo K; Akiyama H; Nomura M; Moriwaki Y
Hepatogastroenterology; 2000; 47(32):586-9. PubMed ID: 10791244
[TBL] [Abstract][Full Text] [Related]
53. [Diagnosis and therapeutic management of gastric lymphomas].
Grau E; Perella M; Gómez A; Pastor E; Mirabet MD; García F; Ibáñez JL; Aguiló J
Sangre (Barc); 1996 Apr; 41(2):109-14. PubMed ID: 9045350
[TBL] [Abstract][Full Text] [Related]
54. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
[TBL] [Abstract][Full Text] [Related]
55. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
[TBL] [Abstract][Full Text] [Related]
56. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
Roukos DH; Lorenz M; Encke A
Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
[TBL] [Abstract][Full Text] [Related]
57. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
Cho BC; Jeung HC; Choi HJ; Rha SY; Hyung WJ; Cheong JH; Noh SH; Chung HC
J Surg Oncol; 2007 May; 95(6):461-8. PubMed ID: 17192913
[TBL] [Abstract][Full Text] [Related]
58. [Lymph node metastasis and the extent of lymph node dissection for gastric cancer: report of 326 cases].
Wan Y; Pan Y; Liu Y; Wang Z; Ye J; Huang S
Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):752-5. PubMed ID: 11832155
[TBL] [Abstract][Full Text] [Related]
59. [The surgical treatment of gastric carcinoma. Evolution in surgical technique and staging in a series of 194 patients].
Tersigni R; Alessandroni L; Baiano G; Mencacci R; Miceli M; Sadighi A; Sorgi G; Tremiterra S
Minerva Chir; 2004 Oct; 59(5):479-87. PubMed ID: 15494675
[TBL] [Abstract][Full Text] [Related]
60. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
